Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
McKesson
Julphar
AstraZeneca
Cantor Fitzgerald
Dow
Daiichi Sankyo
Cerilliant
Harvard Business School

Generated: December 9, 2018

DrugPatentWatch Database Preview

Drugs in Development Information for Solanezumab

« Back to Dashboard

US Patents for Solanezumab

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Solanezumab ➤ Try a Free Trial Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein CureVac AG (Tubingen, DE) ➤ Try a Free Trial
Solanezumab ➤ Try a Free Trial Multimeric peptide conjugates and uses thereof Angiochem Inc. (Montreal, CA) ➤ Try a Free Trial
Solanezumab ➤ Try a Free Trial Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein CureVac AG (Tubingen, DE) ➤ Try a Free Trial
Solanezumab ➤ Try a Free Trial Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients Corning Incorporated (Corning, NY) ➤ Try a Free Trial
Solanezumab ➤ Try a Free Trial Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients Corning Incorporated (Corning, NY) ➤ Try a Free Trial
Solanezumab ➤ Try a Free Trial Detection of misfolded amyloid beta protein AMPRION, INC. (San Diego, CA) THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (Austin, TX) ➤ Try a Free Trial
Solanezumab ➤ Try a Free Trial Combination therapies for the treatment of Alzheimer's disease and related disorders The General Hospital Corporation (Boston, MA) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Solanezumab

Drugname Country Document Number Estimated Expiration Related US Patent
Solanezumab Australia 2010268726 2029-07-02 ➤ Try a Free Trial
Solanezumab Canada 2766537 2029-07-02 ➤ Try a Free Trial
Solanezumab China 102596993 2029-07-02 ➤ Try a Free Trial
Solanezumab European Patent Office 2448965 2029-07-02 ➤ Try a Free Trial
Solanezumab India 248DEN2012 2029-07-02 ➤ Try a Free Trial
Solanezumab Japan 2012531467 2029-07-02 ➤ Try a Free Trial
Solanezumab Japan 5932642 2029-07-02 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
McKinsey
Chinese Patent Office
Dow
Medtronic
AstraZeneca
Merck
Johnson and Johnson
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.